PCR Topics pp 84-88 | Cite as

Diagnosis of Cystic Fibrosis — Detection of the Gene Deletion Delta F 508

  • H. Ehrfeld
  • C. Bottner
  • R. Seelig
  • M. Renz


Cystic fibrosis (CF) is an autosomal recessive disorder with an average incidence of 1:2500 in Caucasians. In CF, increased viscosity of exocrine secretions, caused by disturbed permeability of the cellular membrane for chloride ions, leads to gastrointestinal and bronchopulmonary obstruction followed by malabsorption, pneumonia and bronchiectasia. The locus of a putative CF gene could be assigned to chromosome 7q31 and molecular genetic analyses were established with DNA probes for polymorphic markers linked to the CF locus based on RFLP. Studies within CF families and prenatal diagnosis were thus made possible, if an index patient’s haplotype was known [2]. RFLP studies with linked polymorphic DNA markers, however, were not suitable for clinical diagnosis which had to rely on clinical symptoms and nonspecific laboratory tests. Identification and cloning of the CF gene [13, 14] and the discovery of the deletion Delta F 508 [9] provided a new dimension in diagnosis of CF. Found in 68% of CF chromosomes and predominantly associated with a certain haplotype, Delta F 508 seemed to represent the most important mutation involved in CF. It is to a great extent found in CF patients with insufficient pancreatic function. Delta F 508 causes the loss of phenylalanine in a supposed CF transmembrane regulation protein, which affects a prospective ATP-binding site and thus a regular transport of chloride ions [13].


Cystic Fibrosis Prenatal Diagnosis Cystic Fibrosis Patient Allele Specific Primer Cystic Fibrosis Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ballabio A, Gibbs RA, Caskey CT (1990) PCR test for cystic fibrosis deletion. Nature 343: 220PubMedCrossRefGoogle Scholar
  2. 2.
    Boat TF, Welsh MJ, Beaudet AL (1989) Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (ed), The Metabolic Basis of inherited Disease II, sixth edition, McGraw-Hill New York, pp 2649–2680Google Scholar
  3. 3.
    Dumur V, Lafitte JJ, Gervais R, Debaecker D, Kesteloot M, Lalau G, Roussel P (1990) Abnormal distribution of cystic fibrosis Delta F 508 allele in adults with chronic bronchial hypersecretion. Lancet 335: 1340PubMedCrossRefGoogle Scholar
  4. 4.
    Ehrfeld H, Essrich M, Bottner C, Seelig R (1990) Diagnostik der Mukoviszidose -Nachweis der Gendeletion Delta F 508 mittels PCR. Lab med 14: 187–190Google Scholar
  5. 5.
    Estivill X, Farrall M, Williamson R, Ferrari M, Seia M, Guinta AM, Novelli G, Potenza L, Dalla Piccola B, Borgo B, Gasparini P, Piganatti PF, de Benedetti L, Vitale E, Devoto M, Romeo G (1988) Linkage disquilibrium between cystic fibrosis and linked DNA polymorphisms in Italian families: a collaborative study. Am J Human Genet 43: 23–28Google Scholar
  6. 6.
    Estivill X, Casals T, Morral N, Chillon M, Bosch A, Nunes V, Gasparini P, Seia A, Pignatti PF, Novelli G, Dalla Piccola B, Fernandez E, Benitez J, Williamson R (1989) Delta F 508 gene deletion in cystic fibrosis in Southern Europe. Lancet II: 1404CrossRefGoogle Scholar
  7. 7.
    Fujimura FK, Northrup H, Beaudet AL, Brien WE (1990) Genotyping errors with the polymerase chain reaction. N Engl J Med 322: 61PubMedGoogle Scholar
  8. 8.
    Halley DJJ, van Damme NHM, Deelen WH, Oostra BA, Jahoda MGJ, Sachs ES, Los FJ, Niermeijer MF (1989) Prenatal detection of major cystic fibrosis mutation. Lancet 11:72Google Scholar
  9. 9.
    Kerem BS, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC (1989) Identification of the cystic fibrosis gene: Genetic analysis. Science 245: 1073–1080PubMedCrossRefGoogle Scholar
  10. 10.
    Lemna WK, Feldman GL, Kerem BS, Fernbach SD, Zevkovich EP, O’Brien WE, Riordan JR, Collins FS, Tsui LC, Beaudet AL (1990) Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med 322: 291–296PubMedCrossRefGoogle Scholar
  11. 11.
    Mcintosh I, Lorenzo ML, Brock DJH (1989) Frequency of Delta F 508 mutation on cystic fibrosis chromosomes in UK. Lancet II: 1404–1405CrossRefGoogle Scholar
  12. 12.
    Mcintosh I, Raeburn A, Curtis G, Brock DJH (1989) First-trimester prenatal diagnosis of cystic fibrosis by direct gene probing. Lancet II: 72–73Google Scholar
  13. 13.
    Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui LC (1989) Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245: 1066–1073PubMedCrossRefGoogle Scholar
  14. 14.
    Rommens JM, Iannuzzi MC, Kerem BS, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsui LC, Collins FS (1989) Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 245: 1059–1065PubMedCrossRefGoogle Scholar
  15. 15.
    White MB, Amos J, Hsu JMC, Gerrard B, Finn P, Dean M (1990) A frame-shift mutation in the cystic fibrosis gene. Nature 344: 665–667PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • H. Ehrfeld
  • C. Bottner
  • R. Seelig
  • M. Renz

There are no affiliations available

Personalised recommendations